BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18818406)

  • 1. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling.
    Swendeman S; Mendelson K; Weskamp G; Horiuchi K; Deutsch U; Scherle P; Hooper A; Rafii S; Blobel CP
    Circ Res; 2008 Oct; 103(9):916-8. PubMed ID: 18818406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes.
    Weskamp G; Mendelson K; Swendeman S; Le Gall S; Ma Y; Lyman S; Hinoki A; Eguchi S; Guaiquil V; Horiuchi K; Blobel CP
    Circ Res; 2010 Mar; 106(5):932-40. PubMed ID: 20110534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal cleavage and release of the ectodomain of Flt1 is mediated via ADAM10 and ADAM 17 and regulated by VEGFR2 and the Flt1 intracellular domain.
    Raikwar NS; Liu KZ; Thomas CP
    PLoS One; 2014; 9(11):e112794. PubMed ID: 25387128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.
    Le Gall SM; Bobé P; Reiss K; Horiuchi K; Niu XD; Lundell D; Gibb DR; Conrad D; Saftig P; Blobel CP
    Mol Biol Cell; 2009 Mar; 20(6):1785-94. PubMed ID: 19158376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
    Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
    Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.
    Maretzky T; Evers A; Zhou W; Swendeman SL; Wong PM; Rafii S; Reiss K; Blobel CP
    Nat Commun; 2011; 2():229. PubMed ID: 21407195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.
    Maretzky T; Zhou W; Huang XY; Blobel CP
    Oncogene; 2011 Feb; 30(5):611-8. PubMed ID: 20871631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antiatherogenic Effect of Fish Oil in Male Mice Is Associated with a Diminished Release of Endothelial ADAM17 and ADAM10 Substrates.
    Speck N; Brandsch C; Schmidt N; Yazdekhasti N; Hirche F; Lucius R; Rimbach G; Stangl GI; Reiss K
    J Nutr; 2015 Jun; 145(6):1218-26. PubMed ID: 25926412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
    Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
    J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis.
    Caolo V; Swennen G; Chalaris A; Wagenaar A; Verbruggen S; Rose-John S; Molin DG; Vooijs M; Post MJ
    Angiogenesis; 2015 Jan; 18(1):13-22. PubMed ID: 25218057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.
    Sisto M; Lisi S; Lofrumento DD; D'Amore M; Frassanito MA; Ribatti D
    Genes Immun; 2012 Jul; 13(5):411-20. PubMed ID: 22513453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
    Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J
    Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro.
    Li J; Liu B; Gao X; Ma Z; CaoSong T; Mei YA; Zheng Y
    Protein Cell; 2012 Feb; 3(2):153-9. PubMed ID: 22322890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2 receptor-mediated epidermal growth factor receptor transactivation through a disintegrin and metalloprotease regulates dopaminergic neuron development via extracellular signal-related kinase activation.
    Yoon S; Baik JH
    J Biol Chem; 2013 Oct; 288(40):28435-46. PubMed ID: 23955337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor regulates stanniocalcin-1 expression via neuropilin-1-dependent regulation of KDR and synergism with fibroblast growth factor-2.
    Holmes DI; Zachary IC
    Cell Signal; 2008 Mar; 20(3):569-79. PubMed ID: 18164591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis.
    Donners MM; Wolfs IM; Olieslagers S; Mohammadi-Motahhari Z; Tchaikovski V; Heeneman S; van Buul JD; Caolo V; Molin DG; Post MJ; Waltenberger J
    Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2188-95. PubMed ID: 20814017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the sheddase activity of ADAM17 by an anti-ADAM17 antibody D1(A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs transactivation.
    Huang Y; Benaich N; Tape C; Kwok HF; Murphy G
    Int J Biol Sci; 2014; 10(7):702-14. PubMed ID: 25013379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.